Makary pointed to three bottlenecks: hospital contracting; ethical reviews and approvals; and the Investigational New Drug applications process ...
A policy change allowing approval of some new drugs based on one adequate and well-controlled study could accelerate ...
The Food and Drug Administration (FDA) development and approval process for drugs and medical devices involves multiple phases that ensure the safety and effectiveness of products before and after ...
Broadcast Retirement Network's Jeffrey Snyder discusses the use of Artificial Intelligence in the creation of new drug with Early-Stage Biotech Scientist Andrew R. Snyder, PhD.
Explore how patient experience data shapes regulatory drug decisions, enhancing the patient-focused drug development initiative for better treatment outcomes. Patient experience data are critical to ...
FRANKFURT, Germany--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, will showcase its latest flexible solutions to help boost efficiency and scale in ...